The Staphylococcus aureus serine protease-like protein B is a potent allergen in a murine asthma model
Synopsis
Using repeated intratracheal inoculation of mice with recombinant Staphylococcus aureus serine protease-like protein B (SplB) or an inactive mutant, this study found that SplB sensitized mice and caused eosinophilic airway inflammation and hyperresponsiveness, that asthma development required both the proteolytic activity of SplB and a functional adaptive immune system, and that the soluble protease sensor IL-33 was necessary for eosinophil tissue invasion whereas the membrane-bound protease sensor PAR2 was not, leading the authors to propose a third mechanism in which S. aureus releases allergens such as SplB that sensitize individuals and lead to asthma.
Interpretation
Intratracheal exposure to SplB sensitized mice and caused eosinophilic airway inflammation and hyperresponsiveness. Two hypotheses previously explained the link between asthma and S. aureus colonization, namely that the allergic environment favors colonization or that colonization creates a pro-allergic environment; this study directly asked whether the pathogen itself can cause asthma and proposed a third mechanism in which S. aureus releases allergens. Based on a mouse model, with allergic airway inflammation assessed by airway hypersensitivity, immune cell infiltration, cytokines, mucus production, fibrosis, and specific serum IgE.
Asthma development required both the proteolytic activity of SplB and a functional adaptive immune system. By comparing catalytically active SplB with an inactive mutant and comparing wild-type with gene-deficient C57BL/6J mice including Rag2-/-, the study attributed allergen activity to protease activity and localized the involvement of adaptive immunity. Uses a catalytically active versus inactive mutant comparison and Rag2-/- gene-deficient mouse comparison.
The soluble protease sensor IL-33 was necessary for eosinophil tissue invasion, whereas the membrane-bound protease sensor PAR2 was not. It distinguishes the roles of two protease sensors in SplB-induced allergic airway inflammation, positioning IL-33 as a key step for eosinophil tissue invasion. Derived from comparison of Il33-/- and F2rl1-/- (PAR2) gene-deficient mice.
Perspective
The study establishes in a mouse model that SplB acts as an allergen that can sensitize and induce allergic airway inflammation, relevant to mechanistic research on the S. aureus colonization-asthma relationship and to intervention ideas targeting SplB; its conclusions are set in C57BL/6J mice receiving repeated intratracheal SplB inoculation, and extension to human asthma requires separate validation.
The source is abstract-level content without figures or specific values, so effect sizes, dosing, and timing details cannot be assessed; the relevance of SplB to human asthma, the role of other S. aureus allergens, and the division of labor between IL-33 and PAR2 across inflammatory steps remain open questions worth watching.